Technology in Clinical Trials - A new pragmatism emerging with patients at the core

On Demand

This Solution Provider Webinar is brought to you by DIA in cooperation with PAREXEL.

In this webinar...

Parexel is at the forefront of change. We make studies more accessible by deploying our virtual trials service to reduce the practical, financial and geographical barriers to participation, thereby achieving better recruitment and retention.

Decentralized Clinical Trials – also called virtual/remote/siteless trials (Ph I-III) or direct-to-patient (DTP) /direct-with-patient (DWP) studies (Ph IV) – are designed to make it as easy as possible for patients to participate in clinical research by taking all or part of the study to them in their homes or local community.

Learning Objectives

  • Why are Decentralized Clinical Trials (DCT) important?
  • Why Parexel’s Decentralized Clinical Trials are different?
  • How we are driving innovation through partnering?


  • Sanjay Vyas, SVP and Managing Director, Parexel International
  • Roopa Basrur, Vice President and Country Head, Calyx India